RZNOMICS: 1ST FOCUSED MEETING FOR GENE AND RNA THERAPEUTICS

Date and Time

06 November 2023 (Monday)

08:00 AM TO 11:30 AM (CET)

04:00 PM TO 07:30 PM (KST)

Event Details

We are excited to extend FREE invitation for Rznomics Inc.'s 1st Focused Meeting for Gene and

RNA Therapeutics!

Rznomics Inc., is a RNA therapeutics company devoted to preclinical and clinical studies for rare and

incurable diseases with trans-splicing ribozyme and its delivery vehicle, and our pipeline RZ-001 for

hepatocellular carcinoma (HCC) and glioblastoma (GBM) has been approved for phase 1/2a clinical trial 

by U.S. FDA and Korean Ministry of Food and Drug Safety, and HCC combination 1b/2a IND submission to

Korean MFDS has also been completed. Recently, we were selected as one of the 50 Best Companies in T

echnology Development for Small and Medium-sized Businesses by Korean Government Ministry.

Join us at this Hybrid Meeting: Onsite at Novotel Munchen Messe, Germany or Online via EventX and dive into the Gene and RNA Therapeutics latest developments and insights!

* You will be receiving a registration link upon registration.